Cargando…

Upregulation of Phosphodiesterase type 5 in the Hyperplastic Prostate

Both erectile dysfunction (ED) and lower urinary tract symptoms (LUTS)/benign prostatic hyperplasia (BPH) are common in the aging male. Numerous clinical trials have demonstrated the efficacy and safety of phosphodiesterase type 5 inhibitors (PDE5-Is) for treating LUTS/BPH with/without ED. However,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Wenhao, Zang, Ning, Jiang, Yaoming, Chen, Ping, Wang, Xinghuan, Zhang, Xinhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674741/ https://www.ncbi.nlm.nih.gov/pubmed/26657792 http://dx.doi.org/10.1038/srep17888

Ejemplares similares

Upregulation of Oxytocin Receptor in the Hyperplastic Prostate
por: Li, Zhuo, et al.
Publicado: (2018)

Identification and functional activity of matrix-remodeling associated 5 (MXRA5) in benign hyperplastic prostate
por: Xiao, He, et al.
Publicado: (2020)

Glucose-regulated protein 78 modulates cell growth, epithelial–mesenchymal transition, and oxidative stress in the hyperplastic prostate
por: Fu, Xun, et al.
Publicado: (2022)

Alterations in the phosphodiesterase type 5 pathway and oxidative stress correlate with erectile function in spontaneously hypertensive rats
por: He, Weixiang, et al.
Publicado: (2020)

Changes in the Expression and Functional Activities of C-X-C Motif Chemokine Ligand 13 (CXCL13) in Hyperplastic Prostate
por: Liu, Daoquan, et al.
Publicado: (2022)

Systematic Review and Meta-Analysis of the Use of Phosphodiesterase Type 5 Inhibitors for Treatment of Erectile Dysfunction following Bilateral Nerve-Sparing Radical Prostatectomy
por: Wang, Xiao, et al.
Publicado: (2014)

Upregulated Interleukin 21 Receptor Enhances Proliferation and Epithelial-Mesenchymal Transition Process in Benign Prostatic Hyperplasia
por: Xu, Deqiang, et al.
Publicado: (2019)

Glutathione Peroxidase 3 induced mitochondria-mediated apoptosis via AMPK /ERK1/2 pathway and resisted autophagy-related ferroptosis via AMPK/mTOR pathway in hyperplastic prostate
por: Li, Yan, et al.
Publicado: (2023)

The Role of Heat Shock Protein 70 Subfamily in the Hyperplastic Prostate: From Molecular Mechanisms to Therapeutic Opportunities
por: Fu, Xun, et al.
Publicado: (2022)

Lycopene and Risk of Prostate Cancer: A Systematic Review and Meta-Analysis
por: Chen, Ping, et al.
Publicado: (2015)

Qianlongtong Inhibits Proliferation and Induces Apoptosis of Hyperplastic Prostate Cells
por: Yuan, Yifeng, et al.
Publicado: (2018)

A comparison of retinol binding in human hyperplastic and malignant prostate.
por: Boyd, D., et al.
Publicado: (1985)

Phosphodiesterase type 5 inhibitors usage and prostate cancer: a match-paired analysis
por: Machen, G. Luke, et al.
Publicado: (2017)

Clinicopathological and molecular analyses of hyperplastic lesions including microvesicular variant and goblet cell rich variant hyperplastic polyps and hyperplastic nodules—Hyperplastic nodule is an independent histological entity
por: Uesugi, Noriyuki, et al.
Publicado: (2021)

Hyperplastic Human Macromass Cartilage for Joint Regeneration
por: Wen, Ya, et al.
Publicado: (2023)

Comparison of 66 chemical element contents in normal and benign hyperplastic prostate
por: Zaichick, Vladimir, et al.
Publicado: (2019)

The role of phosphodiesterase-5 inhibitors in prostatic inflammation: a review
por: Peixoto, Christina Alves, et al.
Publicado: (2015)

Transgelin-2 is upregulated on activated B-cells and expressed in hyperplastic follicles in lupus erythematosus patients
por: Kiso, Kaori, et al.
Publicado: (2017)

Phosphodiesterase type 5 and cancers: progress and challenges
por: Barone, Ines, et al.
Publicado: (2017)

Traumatic Brain Injury Upregulates Phosphodiesterase Expression in the Hippocampus
por: Wilson, Nicole M., et al.
Publicado: (2016)

Phosphodiesterase Type 5 Inhibitors Synergize Vincristine in Killing Castration-Resistant Prostate Cancer Through Amplifying Mitotic Arrest Signaling
por: Hsu, Jui-Ling, et al.
Publicado: (2020)

Quantitative volumetric imaging of normal, neoplastic and hyperplastic mouse prostate using ultrasound
por: Singh, Shalini, et al.
Publicado: (2015)

COVID-19 and Phosphodiesterase Enzyme Type 5 Inhibitors
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2020)

Phosphodiesterase 10A Upregulation Contributes to Pulmonary Vascular Remodeling
por: Tian, Xia, et al.
Publicado: (2011)

Hyperplastic proliferations of the ECL cells.
por: Dayal, Y.
Publicado: (1992)

No Causal Link between Phosphodiesterase Type 5 Inhibition and Melanoma
por: Wang, Jenny Z., et al.
Publicado: (2019)

AB030. Evolution of phosphodiesterase type 5 inhibitors
por: Moon, Du Geon
Publicado: (2016)

Determination of Phosphodiesterase Type-5 Inhibitors (PDE-5) in Dietary Supplements
por: Gheorghiu, Oana Ramona Cătălina, et al.
Publicado: (2023)

Phosphodiesterase Type-5 Inhibitor Tadalafil Modulates Steroid Hormones Signaling in a Prostate Cancer Cell Line
por: Bimonte, Viviana M., et al.
Publicado: (2021)

Green tea and the risk of prostate cancer: A systematic review and meta-analysis
por: Guo, Yuming, et al.
Publicado: (2017)

Hyperplastic Cardiac Sarcoma Recurrence
por: Shariff, Masood A., et al.
Publicado: (2015)

Hyperplastic Polyps and Gastroduodenal Pseudomelanosis
por: Agrawal, Akanksha, et al.
Publicado: (2017)

QUANTITATIVE STUDIES OF PROSTATIC SECRETION : II. THE EFFECT OF CASTRATION AND OF ESTROGEN INJECTION ON THE NORMAL AND ON THE HYPERPLASTIC PROSTATE GLANDS OF DOGS
por: Huggins, Charles, et al.
Publicado: (1940)

Human-like hyperplastic prostate with low ZIP1 induced solely by Zn deficiency in rats
por: Fong, Louise Y., et al.
Publicado: (2018)

Phosphodiesterase Type 5 Inhibitors and sudden sensorineural hearing loss
por: Barreto, Monique Antunes de Souza Chelminski, et al.
Publicado: (2015)

Phosphodiesterase type 5 inhibitors: Irrational use in Saudi Arabia
por: Alshahrani, Saad, et al.
Publicado: (2016)

Reactive Hyperplastic Lesions of the Oral Cavity
por: Kadeh, Hamideh, et al.
Publicado: (2015)

Evolution of Phosphodiesterase-5 Inhibitors
por: Moon, Du Geon
Publicado: (2015)

Repurposing phosphodiesterase-5 inhibitors as chemoadjuvants
por: Tiwari, Amit K., et al.
Publicado: (2013)

The impact of surgical treatments for lower urinary tract symptoms/benign prostatic hyperplasia on male erectile function: A systematic review and network meta-analysis
por: Li, Zhuo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4dh13m2l8a1vet394pmrh37l91